Publication | Closed Access
Pegylated liposomal doxorubicin (doxil): Reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2
611
Citations
23
References
2000
Year
Cardiovascular DiseaseMedicineCardiovascular PharmacologyLiposomal DoxorubicinClinical PharmacologyCumulative DosesPharmacotherapyClinical CardiotoxicityCardiovascular ToxicityPharmacologyCardiology
| Year | Citations | |
|---|---|---|
Page 1
Page 1